Diluted EPS came in at $-0.31, missed the $-0.22 consensus by $0.09.
Filings will appear here once submitted to SEC EDGAR.
Common questions about Medicus Pharma's Q3 2024 earnings report.
Medicus Pharma (MDCX) reported Q3 2024 earnings on November 22, 2024 before market open.
Medicus Pharma reported diluted EPS of $-0.31 for Q3 2024.
EPS missed the consensus estimate of $-0.22 by $0.09.